4D Molecular Therapeutics, Inc. ($FDMT)
Filing Information
| Accession Number | 0001193125-26-382245 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,752
Total Value
$11,966.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 584 | $6.49 | $3,790.16 | 9,201 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Sep 1, 2026 | Sale | 584 | $14.00 | $8,176.00 | 8,617 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 584 | $0.00 | $0.00 | 2,959 | Direct | โ | View Details |